Healthspan Horizons has joined the Global Healthspan Extension Consortium, an international collaborative effort coordinated by Heike A. Bischoff-Ferrari, to accelerate the clinical translation of multi-omics biomarkers for healthspan promotion.
The consortium brings together leading academic institutions, clinical researchers, and translational science partners to address one of the central challenges in longevity medicine: how to reliably measure biological aging, detect early deviations from healthy trajectories, and evaluate the effectiveness of interventions before disease onset. By integrating genomics, proteomics, metabolomics, and other high-dimensional biological signals, the consortium aims to establish clinically actionable biomarkers that can be deployed across diverse populations and care settings.
Through this collaboration, Healthspan Horizons contributes its expertise in systems biology, data integration, and healthspan intelligence to help bridge discovery science and real-world clinical application. The work supports a future in which healthspan can be monitored dynamically, interventions can be personalized and tracked over time, and prevention becomes a measurable, evidence-based pillar of healthcare.
